Press Release June 12, 2023 Opioid-related Disorders Market expected to rise | Companies – GW Pharmaceuticals, Opiant Pharmaceuticals, Trevi Therapeutics, Aphios, Astellas Pharma, expected to drive market
Press Release June 12, 2023 Groupon (GRPN) reveals transformation plans as stock performance points to an impending positive turnaround
Press Release June 12, 2023 Gastroesophageal Reflux Disease Pipeline Review | Latest Drug Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | AstraZeneca, Aurobindo Pharma Limited, Cadila Pharma
Press Release June 12, 2023 Exploring Novel Approaches to Pulmonary Arterial Hypertension Pipeline and Clinical Trials (2023) | Companies – Merck Sharp & Dohme, Acceleron Pharma, Liquidia Technologies, Gossamer Bio, and others
Press Release June 12, 2023 Unveiling the Future of Molluscum Contagiosum Treatment & Pipeline Insights (2023) | Companies – Novan, Veloce Biopharma, Verrica Pharmaceuticals, Santalis Healthcare, Synteract Inc, and others
Press Release June 12, 2023 Advancements in Major Depressive Disorder Pipeline: A Comprehensive Insight (2023) | Companies – GH Research, Praxis Precision Medicines, AbbVie, Gedeon Richter, Intra-Cellular Therapies, and others
Press Release June 12, 2023 Gene And Cell Therapies In Rare Disorders Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight
Press Release June 12, 2023 Gastrointestinal Stromal Tumor Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Jiangsu Hengrui Medicine, Daiichi Sankyo Company, Cogent Biosciences
Press Release June 12, 2023 Osteoarthritis Pipeline and Clinical Trials Assessment 2023: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Bone Therapeutics, Moebius Medical, UnicoCell Biomed, Astrazeneca